RA Capital Management - PROGENICS PHARMACEUTICALS IN ownership

PROGENICS PHARMACEUTICALS IN's ticker is PGNX and the CUSIP is 743187106. A total of 153 filers reported holding PROGENICS PHARMACEUTICALS IN in Q3 2018. The put-call ratio across all filers is 1.25 and the average weighting 0.1%.

Quarter-by-quarter ownership
RA Capital Management ownership history of PROGENICS PHARMACEUTICALS IN
ValueSharesWeighting
Q3 2018$19,000,0003,030,3031.02%
Other shareholders

There were no reported owners of PROGENICS PHARMACEUTICALS IN in Q3 2018.

NameSharesValueWeighting ↓
View complete list of PROGENICS PHARMACEUTICALS IN shareholders